Medhin Lidia B, Tekle Lia A, Fikadu Daniel T, Sibhatu Danait B, Gebreyohans Samson F, Gebremichael Kibrom H, Halki Tesfamariam M, Said Saleh M, Ghidei Yosief T, Lobeck Hartmut
Pathology, National Health Laboratory, Asmara, Eritrea.
Microbiology, National Health Laboratory, Asmara, Eritrea.
Int J Breast Cancer. 2019 Jul 1;2019:8536548. doi: 10.1155/2019/8536548. eCollection 2019.
In Africa, breast cancer closely compares with cervical cancer as the most common malignancy affecting women and the incidence rates appear to be rising. Eritrea is experiencing a growing breast cancer problem, but little is presently known on tumor patterns, breast cancer epidemiology, and risk factors. The main objective of this study is to provide baseline data on breast cancer incidence in both sexes in Eritrea. This study was carried out retrospectively and quantitatively by collecting, abstracting, analyzing, coding, and interpreting data recorded in National Health Laboratory (NHL) using CanReg5 ver. 5.00.35. Extracting and classification of the tumor data was done using topography, morphology together with the ICD-10. To generate the incidence rate for the seven years the Eritrean population dataset was used from the population pyramid net for 2014. After we entered all the data from Pathology department in NHL, data was analyzed using the predetermined and developed built-in analysis tools of CanReg5 software and Microsoft Excel 2010. A total number of 9,403 pathology cases were recorded from 2011 to 2017. Out of these 1,497 cases were confirmed as cytology and histology of breast cases. From 1,497 confirmed breast cases in both sexes, the incidence of benign cases was higher than incidence of malignant cases with the case number of 1, 149, and 348, respectively. Out of the 1,497 cases, 1,447 (96.66%) were females; this included a total incidence cases of female benign and malignant breast cases 1,111 (76.78%), and 336 (23.22%), respectively. In both female and male age group the highest positive cases were found in the age greater than 85. The incidence age standard rate per 100,000 in females and male was 3.3 and 0.2, respectively. In sum, the age standardized incidence of breast cancer was relatively low. However, it is our opinion that the low prevalence may be due to low awareness and a highly centralized screening and diagnostic services. This limits access. Altogether, it is our opinion that breast cancer presents a burden to Eritrean ministry of health.
在非洲,乳腺癌与宫颈癌一样,是影响女性的最常见恶性肿瘤,且发病率似乎在上升。厄立特里亚正面临日益严重的乳腺癌问题,但目前对肿瘤模式、乳腺癌流行病学及风险因素了解甚少。本研究的主要目的是提供厄立特里亚男女乳腺癌发病率的基线数据。本研究通过收集、提取、分析、编码和解释国家卫生实验室(NHL)使用CanReg5版本5.00.35记录的数据进行回顾性定量研究。肿瘤数据的提取和分类采用部位、形态学以及国际疾病分类第十版(ICD - 10)进行。为计算七年的发病率,使用了2014年人口金字塔网的厄立特里亚人口数据集。将NHL病理科的所有数据录入后,使用CanReg5软件和Microsoft Excel 2010预先设定并开发的内置分析工具进行数据分析。2011年至2017年共记录了9403例病理病例。其中1497例经确诊为乳腺病例的细胞学和组织学检查。在1497例确诊的男女乳腺病例中,良性病例的发病率高于恶性病例,病例数分别为1149例和348例。在这1497例病例中,1447例(96.66%)为女性;其中女性乳腺良性和恶性病例的总发病率分别为1111例(76.78%)和336例(23.22%)。在女性和男性年龄组中,阳性病例数最高的均为85岁以上人群。女性和男性每10万人的发病率年龄标准化率分别为3.3和0.2。总之,乳腺癌的年龄标准化发病率相对较低。然而,我们认为低患病率可能是由于意识淡薄以及筛查和诊断服务高度集中,这限制了可及性。总体而言,我们认为乳腺癌给厄立特里亚卫生部带来了负担。